Ergebnis der Suchanfrage nach Großhadern

Fördergesellschaft IZB mbH

Innovation and Start-up Center Biotechnology (IZB) welcomes Invitris

Fördergesellschaft IZB mbH

Innovation and Start-Up Center for Biotechnology (IZB) welcomes new start-up Origin.Bio

Fördergesellschaft IZB mbH

2

The start-up Eisbach Bio in the IZB near Munich receives 6.7 million euros from the Bavarian state government for the development of a COVID-19 therapeutics

Fördergesellschaft IZB mbH

2

Mk2 Biotechnolgies new start-up at the Innovation and Start-up Center Biotechnology (IZB) in Martinsried, near Munich, Germany

Fördergesellschaft IZB mbH

2

COVID-19: Start-up Eisbach Bio at the IZB receives EUR 8 million government grant

Fördergesellschaft IZB mbH

7

Biotech start-ups at the IZB close deals worth more than 140 million EUR in the first half of 2021

Fördergesellschaft IZB mbH

3

IZB-Start-up AMSilk receives financing of 29 million euros

Fördergesellschaft IZB mbH

2

Lindis Biotech develops immunotherapy against bladder cancer

Fördergesellschaft IZB mbH

Origenis founds biotech company Neuron23 in Silicon Valley together with star investor Kleiner Perkins

Fördergesellschaft IZB mbH

4

ChromoTek and Absolute Antibody Collaborate on Recombinant Engineered Antibodies

Technische Universität München

New synthetic peptides could attenuate atherosclerosis

Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36446/ NEWS RELEASE New synthetic peptides could attenuate atherosclerosis Synthetic “mini” receptors block atherosclerosis Atherosclerosis, a lipid-triggered chronic inflammatory disease of our arteries, is the main cause of strokes and ...

Fördergesellschaft IZB mbH

2

A higher omega-3 level apparently protects from dying from COVID-19

Fördergesellschaft IZB mbH

3

World Cancer Day: Start-ups at the IZB develop innovative cancer drugs and diagnostic tools

Fördergesellschaft IZB mbH

KOPIE VON: Commemorative publication for the 25th anniversary of the IZB presents 70 profiles and visions of successful biotech start-ups

Enclosed we send you the news of the day about the IZB. We would be pleased if you would consider the message in your news coverage. If you have any question ...

Fördergesellschaft IZB mbH

5

Commemorative publication for the 25th anniversary of the IZB presents 70 profiles and visions of successful biotech start-ups

Fördergesellschaft IZB mbH

2

Proteintech Acquires ChromoTek, Expanding its Next Generation Antibody Tools

Fördergesellschaft IZB mbH

KOPIE VON: Inspirational talks form SIRION Biotech, CLS Behring and the German Accelerator at the 13th Biotech Press Lounge at the IZB

Fördergesellschaft IZB mbH

Inspirational talks form SIRION Biotech, CLS Behring and the German Accelerator at the 13th Biotech Press Lounge at the IZB

Fördergesellschaft IZB mbH

The development of a combination drug for immunotherapy and trends of the VC and pharmaceutical branch were introduced at the IZB

Fördergesellschaft IZB mbH

High investor density at the Pitch Day hosted by IZB

Fördergesellschaft IZB mbH

ChromoTek has launched next level of secondary antibodies

Helmholtz Zentrum München

2

Specific identification of chronic lung disease in premature babies